In addition, PFKFB3 expression was increased in rat PAH model, whereas administration of HMGB1 inhibitor GLY or YAP inhibitor verteporfin (VER) blunted this upregulation in MCT-induced rat PAH model (Fig. 7, B and D). Here, PFKFB3 is linked to pulmonary arterial hypertension.